You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康德萊醫械(01501.HK)擬更名為“上海康德瑛泰醫療器械” 建議採納H股獎勵信託計劃
格隆匯 03-18 23:11

格隆匯3月18日丨康德萊醫械(01501.HK)宣佈,董事會建議將公司的英文名稱由“Shanghai Kindly Medical Instruments Co.,Ltd.”更改為“Shanghai INT Medical Instruments Co.,Ltd.”,以及將公司中文名稱由“上海康德萊醫療器械股份有限公司”更改為“上海康德瑛泰醫療器械股份有限公司”

董事會認為,建議名稱上海康德瑛泰醫療器械股份有限公司將有助於建立獨立的企業標識,強化市場對公司自身品牌認知,更好符合公司未來戰略發展規劃。

董事會於2022年3月18日舉行的董事會會議上議決建議採納H股獎勵信託計劃。H股計劃須經股東於股東周年大會上審議及批准後方可作實。H股計劃旨在:(i)提供擁有公司股權的機會,吸引、激勵及挽留技術熟練與經驗豐富的人員為集團的未來發展及擴張而努力;(ii)深化公司薪酬制度改革,發展及不斷完善股東、運營及執行管理人員之間的利益平衡機制;及(iii)(a)肯定公司領導層(包括董事)的貢獻;(b)鼓勵、激勵及挽留對集團持續經營、發展及長期增長作出有利貢獻的本公司領導層;及(c)為公司領導層及長期僱員提供其他獎勵使公司領導層的利益與股東及集團整體利益一致。

為確保H股計劃的順利實施,董事會建議,股東於股東周年大會上批准H股計劃後,股東亦授權董事會及╱或授權人士全權處理H股計劃相關事宜。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account